Monthly Archives: August 2017

New Tennessee law formally recognizes pharmacists as providers – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF New Tennessee law formally recognizes pharmacists as providers – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Tennessee saw major provider status legislation take effect on July … Continue reading

Posted in Pharmacist | Tagged , , , | Leave a comment

ICU Medical and Apace Packaging Recall Products – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF ICU Medical and Apace Packaging Recall Products – APhA submits compounding comments to FDA. – (866) 348-2889 ICU Medical, Inc, is voluntarily recalling one lot of 0.9% sodium chloride injection, … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Issues Draft Guidance Addressing Delayed Enforcement of DSCSA Requirements Related to Product Identifiers – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Issues Draft Guidance Addressing Delayed Enforcement of DSCSA Requirements Related to Product Identifiers – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 FDA issued a draft … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA to Require New Training for Opioid Prescribers – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA to Require New Training for Opioid Prescribers – APhA submits compounding comments to FDA. – (866) 348-2889 Food and Drug Administration (FDA) has introduced a new Risk Evaluation and … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Several states limiting the length of opioid analgesic prescriptions – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Several states limiting the length of opioid analgesic prescriptions – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 At least 17 states have enacted rules to curb … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA to expand public education campaign to focus on prevention of youth e-cigarette use – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA to expand public education campaign to focus on prevention of youth e-cigarette use – APhA submits compounding comments to FDA. – (866) 348-2889 FDA announced Tuesday that it will … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Association of dissemination of an educational communication tool with docusate administration – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Association of dissemination of an educational communication tool with docusate administration – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Canadian researchers examined how docusate administration is … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Alabama Pharmacist Defense Lawyer

Alabama Pharmacist Defense Lawyer – Kreps Law Firm, LLC Alabama State Board of Pharmacy is stop 1 for this morning. Always enjoy being in this building helping our clients who are Alabama Pharmacists, Pharmacies or Technicians. – Kreps Law Firm, LLC Call … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Florida officials confirm first case of sexually transmitted Zika – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Florida officials confirm first case of sexually transmitted Zika – APhA submits compounding comments to FDA. – (866) 348-2889 For most Americans, especially pregnant women, concerns about Zika virus disease … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA approves glecaprevir-pibrentasvir for HCV – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA approves glecaprevir-pibrentasvir for HCV – APhA submits compounding comments to FDA. – (866) 348-2889 FDA approved on Thursday glecaprevir–pibrentasvir (Mavyret—AbbVie) for the treatment of adults with chronic hepatitis C … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off